Buscar
Merck & Co Inc
MRKAñadir a la lista de seguimiento
150.360USD
-1.980-1.30%
Cierre 09-04 16:00（ET）
371.11BCap. mercado
42.15P/E TTM
Más Datos de Merck & Co Inc Compañía
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Perfil de Merck & Co Inc
Símbolo de cotizaciónMRK
Nombre de la empresaMerck & Co Inc
Fecha de salida a bolsaFeb 06, 2077
Director ejecutivoDavis (Robert M)
Número de empleados75000
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 06
Dirección126 East Lincoln Avenue
CiudadRAHWAY
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07065
Teléfono19087404000
Sitio Webhttps://www.merck.com/
Símbolo de cotizaciónMRK
Fecha de salida a bolsaFeb 06, 2077
Director ejecutivoDavis (Robert M)
Ejecutivos de Merck & Co Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
45.02K
-56.39%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
45.02K
-56.39%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
45.02K
-56.39%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Merck & Co Inc?
Los cinco principales accionistas de Merck & Co Inc son: Mr. Robert M. (Rob) Davis
¿Cuántas instituciones poseen acciones de Merck & Co Inc (MRK)?
A fecha de 2026Q1, 5687 instituciones poseen acciones de Merck & Co Inc, con un valor de mercado combinado de aproximadamente 2.01B, lo que representa el 81.41% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -10595247.00.
¿Cuál es la mayor fuente de ganancias de Merck & Co Inc?
El 2026Q1, el segmento empresarial Oncology-Keytruda generó la ganancia más alta para Merck & Co Inc, ascendiendo a 7.90B y representando el 47.59% de la ganancia total.